1. Home
  2. IMVT vs VIST Comparison

IMVT vs VIST Comparison

Compare IMVT & VIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$39.90

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Vista Energy S.A.B. de C.V. each representing one series A share with no par value

VIST

Vista Energy S.A.B. de C.V. each representing one series A share with no par value

HOLD

Current Price

$64.15

Market Cap

6.7B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMVT
VIST
Founded
2018
2017
Country
United States
Mexico
Employees
N/A
584
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.7B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IMVT
VIST
Price
$39.90
$64.15
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$33.00
$81.33
AVG Volume (30 Days)
1.4M
843.6K
Earning Date
05-28-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.93
Revenue Next Year
N/A
$20.35
P/E Ratio
N/A
$7.99
Revenue Growth
N/A
N/A
52 Week Low
$14.32
$33.37
52 Week High
$41.23
$81.44

Technical Indicators

Market Signals
Indicator
IMVT
VIST
Relative Strength Index (RSI) 61.26 44.12
Support Level $37.53 $63.77
Resistance Level $41.23 $77.59
Average True Range (ATR) 1.47 2.33
MACD -0.22 0.32
Stochastic Oscillator 64.73 55.95

Price Performance

Historical Comparison
IMVT
VIST

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value

Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, it operates in Argentina and Mexico. Product-wise, the firm generates the majority of its revenue from crude oil sales, natural gas sales, and LPG sales.

Share on Social Networks: